MannKind (NASDAQ:MNKD) Raised to Sell at StockNews.com

StockNews.com upgraded shares of MannKind (NASDAQ:MNKD – Get Rating) to a sell rating in a research note published on Thursday. MNKD has been the subject of several other research reports. HC Wainwright lowered their price target on MannKind from $6.50 to $6.00 and set a buy rating for the company in a report on Monday, […]

Related Keywords

United States ,America ,Alfrede Mann ,Anthonyc Hooper ,Alejandro Galindo ,Morgan Stanley ,Emerald Mutual Fund Advisers ,Zacks Investment Research ,Nuveen Asset Management ,Emerald Advisers ,Mannkind Corp ,America Corp ,Get Rating ,Investment Research ,Director Anthony ,Mutual Fund Advisers Trust ,Asset Management ,Mannkind ,Nasdaq Mnkd ,Mnkd ,Medical ,56400p20 ,Upgrade ,Stocknews Com ,